Acute and chronic neurodegenerative disorders affect more than 30 million individuals throughout the world to lead to significant death and disability. A very exciting avenue for neurodegenerative diseases that can offer new strategies for neural regeneration involves the mammalian target of rapamycin (mTOR).
↧